These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Targeting Wnt signaling in colon cancer stem cells. de Sousa EM; Vermeulen L; Richel D; Medema JP Clin Cancer Res; 2011 Feb; 17(4):647-53. PubMed ID: 21159886 [TBL] [Abstract][Full Text] [Related]
3. The inhibition of Wnt/β-catenin signaling pathway in human colon cancer cells by sulindac. Tai WP; Hu PJ; Wu J; Lin XC Tumori; 2014; 100(1):97-101. PubMed ID: 24675499 [TBL] [Abstract][Full Text] [Related]
4. Targeting Wnt signaling: can we safely eradicate cancer stem cells? Takahashi-Yanaga F; Kahn M Clin Cancer Res; 2010 Jun; 16(12):3153-62. PubMed ID: 20530697 [TBL] [Abstract][Full Text] [Related]
5. Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Fodde R; Brabletz T Curr Opin Cell Biol; 2007 Apr; 19(2):150-8. PubMed ID: 17306971 [TBL] [Abstract][Full Text] [Related]
6. Biology of colorectal cancer. Saif MW; Chu E Cancer J; 2010; 16(3):196-201. PubMed ID: 20526096 [TBL] [Abstract][Full Text] [Related]
7. Cancer stem cells - A therapeutic target? Maitland NJ; Collins AT Curr Opin Mol Ther; 2010 Dec; 12(6):662-73. PubMed ID: 21154158 [TBL] [Abstract][Full Text] [Related]
8. Stem cells, melanoma and cancer stem cells: the good, the bad and the evil? Menaa F; Houben R; Eyrich M; Broecker EB; Becker JC; Wischhusen J G Ital Dermatol Venereol; 2009 Jun; 144(3):287-96. PubMed ID: 19088701 [TBL] [Abstract][Full Text] [Related]
9. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180 [TBL] [Abstract][Full Text] [Related]
10. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential. Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798 [TBL] [Abstract][Full Text] [Related]
11. An oncogenic hub: beta-catenin as a molecular target for cancer therapeutics. Takemaru KI; Ohmitsu M; Li FQ Handb Exp Pharmacol; 2008; (186):261-84. PubMed ID: 18491056 [TBL] [Abstract][Full Text] [Related]
12. WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics. Bisson I; Prowse DM Cell Res; 2009 Jun; 19(6):683-97. PubMed ID: 19365403 [TBL] [Abstract][Full Text] [Related]
13. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Shan BE; Wang MX; Li RQ Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933 [TBL] [Abstract][Full Text] [Related]
14. Current status and issues in cancer stem cell study. Yang YM; Chang JW Cancer Invest; 2008 Aug; 26(7):741-55. PubMed ID: 18608212 [TBL] [Abstract][Full Text] [Related]
15. New hope for cancer treatment: exploring the distinction between normal adult stem cells and cancer stem cells. Zhao RC; Zhu YS; Shi Y Pharmacol Ther; 2008 Jul; 119(1):74-82. PubMed ID: 18562010 [TBL] [Abstract][Full Text] [Related]
16. Cancer stem cell: target for anti-cancer therapy. Tang C; Ang BT; Pervaiz S FASEB J; 2007 Dec; 21(14):3777-85. PubMed ID: 17625071 [TBL] [Abstract][Full Text] [Related]
17. Identification of human pancreatic cancer stem cells. Li C; Lee CJ; Simeone DM Methods Mol Biol; 2009; 568():161-73. PubMed ID: 19582426 [TBL] [Abstract][Full Text] [Related]
18. Cancer stem cells in radiation resistance. Rich JN Cancer Res; 2007 Oct; 67(19):8980-4. PubMed ID: 17908997 [TBL] [Abstract][Full Text] [Related]
19. Metabotropic glutamate receptors: new targets for the control of tumor growth? Nicoletti F; Arcella A; Iacovelli L; Battaglia G; Giangaspero F; Melchiorri D Trends Pharmacol Sci; 2007 May; 28(5):206-13. PubMed ID: 17433452 [TBL] [Abstract][Full Text] [Related]
20. BCL9-2 promotes early stages of intestinal tumor progression. Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]